Abstract
Introduction and hypothesis
Recurrent urinary tract infections (UTIs) are more common in women and are frequently defined as ≥2 episodes in the last 6 months or ≥3 episodes in the last 12 months. In a primary care setting, 53 % of women above the age of 55 years and 36 % of younger women report a recurrence within 1 year. Thus, management and prevention of recurrent UTI is of utmost significance. This review aims to highlight the latest research in prevention strategies and suggest a management pathway.
Methods
A search was conducted on MEDLINE, Embase and the Cochrane Database of Systematic Reviews databases for the latest systematic reviews and high-quality randomized controlled trials. Special emphasis was placed on the remit “recurrent” and strongly adhered to. Furthermore, a Google search was conducted for current guidelines on the management of UTIs.
Results
Current prevention strategies include eliminating risk factors that increase the risk of acquiring recurrent UTI and continuous, post-coital and self-initiated antimicrobial prophylaxis. Other prospective preventative strategies, currently under trial, include use of vaccinations, D-mannose and lactobacillus (probiotics).
Conclusion
Although risk factors should be identified and addressed accordingly, individualized antibiotic prophylaxis remains the most effective method of management. Non-antibiotic prevention strategies such as cranberry, vitamin C and methenamine salts lack strong evidence to be introduced as routine management options and as alternatives to antibiotics. Based on current evidence and guidelines, a management pathway is recommended. Emerging therapies require further evaluation before they can be recommended.
Similar content being viewed by others
References
Fihn SD (2003) Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 349(3):259–266
Griebling TL (2005) Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 173(4):1281–1287
Foxman B (1990) Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80(3):331–333
Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE (2000) Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182(4):1177–1182
Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17(4):259–268
Ikäheimo R, Siitonen A, Heiskanen T, Kärkkäinen U, Kuosmanen P, Lipponen P et al (1996) Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 22(1):91–99
Kodner CM, Thomas Gupton EK (2010) Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician 82(6):638–643
Epp A, Larochelle A, Lovatsis D, Walter JE, Easton W, Farrell SA et al (2010) Recurrent urinary tract infection. J Obstet Gynaecol Can 32(11):1082–1101
Nosseir SB, Lind LR, Winkler HA (2012) Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt) 21(3):347–354
Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME (2002) Adult and paediatric urology, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Franco AV (2005) Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 19(6):861–873
American College of Obstetricians and Gynecologists (2008) ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol 111:785–794
Hooton TM, Gupta K (2014) Recurrent urinary tract infection in women. Available via http://www.uptodate.com/contents/recurrent-urinary-tract-infection-in-women
Johnson JR, Clabots C (2006) Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 43(10):e101–e108
Hooton TM, Stapleton AE, Roberts PL, Winter C, Scholes D, Bavendam T et al (1999) Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis 29(6):1600–1601
Nseir W, Taha M, Nemarny H, Mograbi J (2013) The association between serum levels of vitamin D and recurrent urinary tract infections in premenopausal women. Int J Infect Dis 17(12):e1121–e1124
Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE (1998) Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 178:446–450
Gupta K, Trautner BW (2013) Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ 346:f3140
Zaffanello M, Malerba G, Cataldi L, Antoniazzi F, Franchini M, Monti E et al (2010) Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol 2010:321082
Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, Karpman D, Andersson B, Svanborg C (2007) Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 195(8):1227–1234
British Infection Association/Health Protection Agency (2011) Diagnosis of UTI: quick reference guide for primary care (09.07.2014). Available via http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947404720
European Association of Urology (EAU) (2014) Guidelines on urological infections (updated 06.06.2014). Available via http://www.uroweb.org/fileadmin/EAUN/guidelines/Extended_guidelines_GL_2014_final_April.pdf
McIsaac WJ, Moineddin R, Ross S (2007) Validation of a decision aid to assist physicians in reducing unnecessary antibiotic drug use for acute cystitis. Arch Intern Med 167(20):2201–2206
Dason S, Dason JT, Kapoor A (2011) Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 5(5):316–322
Nicolle LE, Mayhew WJ, Bryan L (1987) Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 83:27–33
Scottish Intercollegiate Guidelines Network (2012) SIGN Guideline 88. Management of suspected bacterial urinary tract infection in adults. Available via http://www.sign.ac.uk/guidelines/fulltext/88/index.html
Ninan S, Walton C, Barlow G (2014) Investigation of suspected urinary tract infection in older people. BMJ 349:g4070
Bonkat G, Müller G, Berini A, Frei R, Goldenberger D, Regeniter A et al (2014) Combination of matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) and UX-2000 urine flow-cytometry for rapid detection and identification of urinary tract pathogens. Eur Urol Suppl 13(1):e456
Health Protection Agency (2012) Management of infection guidance for primary care for consultation and local adaptation (updated 22 May 2013). Available via http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1279888711402
Stamm WE, Counts GW, Wagner KF, Martin D, Gregory D, McKevitt M et al (1980) Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med 92(6):770–775
Nicolle LE (1992) Prophylaxis: recurrent urinary tract infection in women. Infection 20(Suppl 3):S203–S205, discussion S206–S210
Al-Badr A, Al-Shaikh G (2013) Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J 13(3):359–367
Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C (2004) Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 3:CD001209
Eells SJ, Bharadwa K, McKinnell JA, Miller LG (2014) Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model. Clin Infect Dis 58(2):147–160
National Institute for Health and Care Excellence (NICE) (2009) Clinical knowledge summaries. Urinary tract infection (lower) - women (22 May 2013). Available via http://cks.nice.org.uk/urinary-tract-infection-lowerwomen-scenariorecommendation:9
Hickling DR, Nitti VW (2013) Management of recurrent urinary tract infections in healthy adult women. Rev Urol 15(2):41–48
Holmberg L, Boman G, Böttiger LE, Eriksson B, Spross R, Wessling A (1980) Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 69(5):733–738
Madani Y, Mann B (2012) Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections. Prim Care Respir J 21(3):337–341
Lichtenberger P, Hooton TM (2011) Antimicrobial prophylaxis in women with recurrent urinary tract infections. Int J Antimicrob Agents 38(Suppl):36–41
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW (2008) Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2:CD005131
Wong ES, McKevitt M, Running K, Counts GW, Turck M, Stamm WE (1985) Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 102(3):302–307
Gupta K, Hooton TM, Roberts PL, Stamm WE (2001) Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 135(1):9–16
Schaeffer AJ, Stuppy BA (1999) Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 161(1):207–211
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120
Stamm WE, Raz R (1999) Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 28(4):723–725
Raz R (2001) Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 183(Suppl 1):S74–S76
Weiderpass E, Baron JA, Adami HO, Magnusson C, Lindgren A, Bergström R et al (1999) Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet 353(9167):1824–1828
Schmidt DR, Sobota AE (1988) An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 55:173
Zafriri D, Ofek I, Adar R, Pocino M, Sharon N (1989) Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 33(1):92–98
Jepson RG, Williams G, Craig JC (2012) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 10:CD001321
Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY et al (2012) Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 172(13):988–996
Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M (2014) Cranberry and recurrent cystitis: more than marketing? Crit Rev Food Sci Nutr 54(8):1063–1075
Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al (2011) Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 171(14):1270–1278
Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarova-Yarovaya Y, Chen S et al (2012) Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 87(2):143–150
Carlsson S, Govoni M, Wiklund NP, Weitzberg E, Lundberg JO (2003) In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria. Antimicrob Agents Chemother 47(12):3713–3718
Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO (2001) Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide 5(6):580–586
Foxman B, Chi JW (1990) Health behavior and urinary tract infection in college-aged women. J Clin Epidemiol 43(4):329–337
Mayrer AR, Andriole VT (1982) Urinary tract antiseptics. Med Clin North Am 66:199–208
Cronberg S, Welin CO, Henriksson L, Hellsten S, Persson KM, Stenberg P (1987) Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study. Br Med J (Clin Res Ed) 294(6586):1507–1508
Gundersen R, Høivik HO, Osmundsen K (1986) Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice (in Norwegian). Tidsskr Nor Laegeforen 106(25):2048–2049
Høivik HO, Gundersen R, Osmundsen K, Halvorsen P, Hjortdahl P, Stokke JG (1984) Prevention of recurrent cystitis in fertile women. A double-blind comparison of Hiprex and placebo in general practice (in Norwegian). Tidsskr Nor Laegeforen 104(16):1150–1152
Lee BB, Simpson JM, Craig JC, Bhuta T (2007) Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 4:CD003265
Altarac S, Papeš D (2014) Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int 113(1):9–10
Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M et al (2005) Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 55(2):441–455
King SS, Young DA, Nequin LG, Carnevale EM (2000) Use of specific sugars to inhibit bacterial adherence to equine endometrium in vitro. Am J Vet Res 61(4):446–449
Kranjčec B, Papeš D, Altarac S (2014) D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 32(1):79–84
Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA et al (2011) Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 52(10):1212–1217
Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al (2012) Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 172:704
Bauer HW, Alloussi S, Egger G, Blümlein HM, Cozma G, Schulman CC et al (2005) A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol 47(4):542–548, discussion 548
Magasi P, Pánovics J, Illés A, Nagy M (1994) Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 26(2):137–140
Schulman CC, Corbusier A, Michiels H, Taenzer HJ (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150(3):917–921
Tammen H (1990) Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol 65(1):6–9
Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT (2007) Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 177(4):1349–1353, quiz 1591
Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE (2003) Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 170(3):867–869
Naber KG, Cho YH, Matsumoto T, Schaeffer AJ (2009) Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 33(2):111–119
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aydin, A., Ahmed, K., Zaman, I. et al. Recurrent urinary tract infections in women. Int Urogynecol J 26, 795–804 (2015). https://doi.org/10.1007/s00192-014-2569-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-014-2569-5